The stock-market hysteria surrounding EntreMed is only the latest in a series of events we list in which an extraordinary quotation dramatically drives up the stock of a company almost overnight. The hype isn't all bad, it turns out.
You may also be interested in...
After double-digit growth in formulation sales across geographies in the fourth quarter, Aurobindo expects to continue the momentum this fiscal year. Meanwhile, it might look for partners for its biologics business, which is now transferred to its fully owned subsidiary for $48m.
The European Commission has updated its rolling plan. It now looks as if current member state rules for non-medical products could persist beyond the 26 May 2021 deadline.
GSK launches a 100% natural saline spray in the UK to compliment its Piri hayfever brand portfolio.